Providence Cancer Center

January 25, 2017

Providence Cancer Center is one of 10 research institutions selected to join the innovative Bristol-Myers Squibb International Immuno-Oncology Network, with focused study on Immunotherapy.

Previous Video
Alaska FinishCancer | Brook’s story
Alaska FinishCancer | Brook’s story

Brook and Ella came out the other side convinced it takes a leap of faith and a lot of love to finish cancer.

Next Video
Providence Cancer Center collaborating globally in the cancer fight
Providence Cancer Center collaborating globally in the cancer fight

Joining the Bristol-Myers Squibb International Immuno-Onocology Network will allow Providence cancer resear...